ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Merrimack Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Merrimack Pharmaceuticals, INC. (Merrimack Pharmaceuticals, INC. 401(k) Retirement Plan · EIN 04-3210530 · PN 001): $464,575 net assets, 3 active participants, and $0.40 per $10,000 (0.40 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorMerrimack Pharmaceuticals, INC.
Filing IdentifierMerrimack Pharmaceuticals, INC. 401(k) Retirement Plan · EIN 04-3210530 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$464,575
Active Participants3
Direct Admin Fee Rate$0.40 per $10,000 (0.40 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI